Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-143' Or cancer = '' Total: 90 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-143 acute myeloid leukemia down Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
hsa-mir-143 acute myeloid leukemia down MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
hsa-mir-143 bladder cancer down LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.
hsa-mir-143 bladder cancer down MicroRNA-143 as a tumor suppressor for bladder cancer.
hsa-mir-143 bladder cancer down MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
hsa-mir-143 bladder cancer down miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling.
hsa-mir-143 bladder cancer down Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
hsa-mir-143 breast cancer down miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
hsa-mir-143 breast cancer down MicroRNA?143 targets CD44 to inhibit breast cancer progression and stem cell-like properties.
hsa-mir-143 breast cancer down MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer.
hsa-mir-143 breast cancer down MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.
hsa-mir-143 cervical cancer down miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.
hsa-mir-143 cervical cancer down A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
hsa-mir-143 cervical cancer down MicroRNA-143 regulates cell migration and invasion by targeting GOLM1 in cervical cancer.
hsa-mir-143 colon cancer down miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.
hsa-mir-143 colon cancer down MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.
hsa-mir-143 colon cancer down The Evi1, microRNA-143, K-Ras axis in colon cancer.
hsa-mir-143 colon cancer down miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation.
hsa-mir-143 colon cancer down Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
hsa-mir-143 colon cancer down Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
hsa-mir-143 colorectal cancer down RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.
hsa-mir-143 colorectal cancer down MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.
hsa-mir-143 colorectal cancer down Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer.
hsa-mir-143 colorectal cancer down The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells.
hsa-mir-143 colorectal cancer down Down-regulation of microRNA-143 is associated with colorectal cancer progression.
hsa-mir-143 colorectal cancer down MicroRNA-143 inhibits colorectal cancer cell proliferation through targeting MMP7.
hsa-mir-143 colorectal cancer down Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma.
hsa-mir-143 colorectal cancer down MicroRNA signatures: novel biomarker for colorectal cancer?
hsa-mir-143 colorectal carcinoma down Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
hsa-mir-143 colorectal carcinoma down [Effect of microRNA143 expression on cell proliferation in colonic carcinoma].
hsa-mir-143 colorectal carcinoma down MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer.
hsa-mir-143 endometrial cancer down MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1.
hsa-mir-143 endometrial cancer down Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
hsa-mir-143 esophageal cancer up Differential expression of miRNAs in esophageal cancer tissue.
hsa-mir-143 esophageal cancer up Alteration of miRNA Expression Correlates with Lifestyle, Social and Environmental Determinants in Esophageal Carcinoma.
hsa-mir-143 esophageal squamous cell carcinoma down MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.
hsa-mir-143 esophageal squamous cell carcinoma down Erratum to: miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
hsa-mir-143 esophageal squamous cell carcinoma down MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma.
hsa-mir-143 esophageal squamous cell carcinoma down miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
hsa-mir-143 gastric cancer down MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
hsa-mir-143 gastric cancer down miR-143 Inhibits Cell Proliferation of Gastric Cancer Cells Through Targeting GATA6.
hsa-mir-143 gastric cancer up Evaluation of MicroRNA Expression Pattern of Gastric Adenocarcinoma Associated with Socioeconomic, Environmental and Lifestyle Factors in Northwestern Hungary.
hsa-mir-143 gastric cancer down MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.
hsa-mir-143 gastric cancer down Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
hsa-mir-143 gastric cancer down [Expression of miR-143 and miR-145 and their functional study in gastric carcinoma].
hsa-mir-143 gastric cancer down Study of miR-143 expression in stomach cancer.
hsa-mir-143 gastric cancer down miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.
hsa-mir-143 glioblastoma down miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143 glioblastoma down miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.
hsa-mir-143 glioblastoma up Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression.
hsa-mir-143 glioma down miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.
hsa-mir-143 hepatocellular carcinoma down [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
hsa-mir-143 hepatocellular carcinoma down MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.
hsa-mir-143 lung cancer up Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development.
hsa-mir-143 lung cancer down Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro.
hsa-mir-143 lung cancer down Effects of miR-143 overexpression on proliferation, apoptosis, EGFR and downstream signaling pathways in PC9/GR cell line.
hsa-mir-143 malignant melanoma down MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.
hsa-mir-143 nasopharyngeal carcinoma down MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma.
hsa-mir-143 nasopharyngeal carcinoma down Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.
hsa-mir-143 nasopharyngeal carcinoma down Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma.
hsa-mir-143 non-small cell lung cancer down miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells.
hsa-mir-143 non-small cell lung cancer down miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.
hsa-mir-143 non-small cell lung cancer down miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.
hsa-mir-143 oral cancer down MicroRNA-143 suppresses oral squamous cell carcinoma (OSCC) cell growth, invasion and glucose metabolism through targeting Hexokinase2.
hsa-mir-143 oral squamous cell carcinoma down Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
hsa-mir-143 oral squamous cell carcinoma down Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
hsa-mir-143 oral squamous cell carcinoma down Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
hsa-mir-143 osteosarcoma down A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
hsa-mir-143 osteosarcoma down microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.
hsa-mir-143 pancreatic ductal adenocarcinoma down XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via DCLK1-Dependent Mechanism.
hsa-mir-143 prostate cancer down miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.
hsa-mir-143 prostate cancer down The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.
hsa-mir-143 prostate cancer down MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.
hsa-mir-143 prostate cancer down miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.
hsa-mir-143 prostate cancer down Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
hsa-mir-143 prostate cancer down Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer.
hsa-mir-143 renal cell carcinoma down The tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
hsa-mir-143 retinoblastoma down Suppressive effect of microRNA-143 in retinoblastoma.
hsa-mir-143 thyroid carcinoma down lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line.
hsa-mir-143-3p breast cancer down miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
hsa-mir-143-3p breast cancer down MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7.
hsa-mir-143-3p cervical cancer down Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p.
hsa-mir-143-3p colorectal cancer down MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3.
hsa-mir-143-3p esophageal squamous cell carcinoma down MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.
hsa-mir-143-3p gallbladder carcinoma down miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
hsa-mir-143-3p gastric cancer down MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2.
hsa-mir-143-3p laryngeal squamous cell carcinoma down MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting Melanoma-Associated Antigen A9 in laryngeal squamous cell carcinoma.
hsa-mir-143-3p malignant melanoma down MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.
hsa-mir-143-3p osteosarcoma down miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.
hsa-mir-143-3p ovarian cancer down MiR-143-3p suppresses the progression of ovarian cancer.